Nuveen Asset Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$742K Hold
56,012
﹤0.01% 2831
2024
Q3
$1.88M Hold
56,012
﹤0.01% 2441
2024
Q2
$1.4M Sell
56,012
-8,228
-13% -$206K ﹤0.01% 2558
2024
Q1
$1.45M Buy
64,240
+11,126
+21% +$251K ﹤0.01% 2542
2023
Q4
$1.14M Sell
53,114
-19,452
-27% -$417K ﹤0.01% 2677
2023
Q3
$1.3M Buy
72,566
+159
+0.2% +$2.86K ﹤0.01% 2465
2023
Q2
$1.47M Sell
72,407
-3,808
-5% -$77.5K ﹤0.01% 2479
2023
Q1
$1.66M Sell
76,215
-83,479
-52% -$1.82M ﹤0.01% 2416
2022
Q4
$4.95M Sell
159,694
-68,088
-30% -$2.11M ﹤0.01% 1908
2022
Q3
$5.81M Sell
227,782
-24,022
-10% -$613K ﹤0.01% 1815
2022
Q2
$5.11M Sell
251,804
-160,843
-39% -$3.26M ﹤0.01% 1919
2022
Q1
$10.9M Sell
412,647
-484
-0.1% -$12.8K ﹤0.01% 1582
2021
Q4
$14.4M Sell
413,131
-7,818
-2% -$272K ﹤0.01% 1449
2021
Q3
$11.4M Buy
420,949
+12,593
+3% +$342K ﹤0.01% 1688
2021
Q2
$10.6M Buy
408,356
+30,649
+8% +$795K ﹤0.01% 1832
2021
Q1
$8.14M Buy
377,707
+220,383
+140% +$4.75M ﹤0.01% 1910
2020
Q4
$3.38M Sell
157,324
-68,280
-30% -$1.47M ﹤0.01% 2254
2020
Q3
$3.33M Sell
225,604
-5,539
-2% -$81.7K ﹤0.01% 2129
2020
Q2
$5.16M Buy
231,143
+7,538
+3% +$168K ﹤0.01% 1881
2020
Q1
$3.16M Buy
223,605
+30,128
+16% +$426K ﹤0.01% 1958
2019
Q4
$3.14M Buy
193,477
+94,212
+95% +$1.53M ﹤0.01% 2232
2019
Q3
$3.47M Sell
99,265
-88
-0.1% -$3.08K ﹤0.01% 2144
2019
Q2
$5.61M Buy
+99,353
New +$5.61M ﹤0.01% 1919